| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.79▲ | 3.83▼ | 3.85▼ | 3.65▲ | 3.30▲ |
| MA10 | 3.83▼ | 3.86▼ | 3.84▼ | 3.45▲ | 2.79▲ |
| MA20 | 3.83▼ | 3.85▼ | 3.82▼ | 3.28▲ | 2.54▲ |
| MA50 | 3.84▼ | 3.69▲ | 3.49▲ | 2.72▲ | 2.37▲ |
| MA100 | 3.86▼ | 3.47▲ | 3.32▲ | 2.50▲ | 3.09▲ |
| MA200 | 3.62▲ | 3.28▲ | 3.01▲ | 2.08▲ | 7.97▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.008▼ | -0.020▼ | -0.023▼ | 0.041▲ | 0.162▲ |
| RSI | 43.246▼ | 48.647▼ | 56.032▲ | 69.295▲ | 71.356▲ |
| STOCH | 14.015▼ | 32.287 | 38.627 | 72.177 | 85.631▲ |
| WILL %R | -83.333▼ | -80.000▼ | -82.353▼ | -18.135▲ | -9.767▲ |
| CCI | -83.784 | -106.332▼ | -101.773▼ | 156.672▲ | 158.090▲ |
| ▼ RSI | $SABS RSI(14) Crossed Below 70 | Set Alert |
|
Friday, November 14, 2025 10:44 PM
Initiated registrational Phase 2b SAFEGUARD trial of SAB-142 in new-onset, Stage 3 autoimmune T1D patientsMultiple SAFEGUARD trial sites activated; on-track to dose first patient by year-endRecent ...
|
|
Friday, November 14, 2025 10:41 PM
SAb Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, ...
|
|
Tuesday, November 04, 2025 03:31 AM
SAb (Nasdaq: SABS ), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 20/11/25 | 3.88 | 3.97 | 3.77 | 3.79 | 143,643 |
| 19/11/25 | 3.90 | 4.00 | 3.71 | 3.83 | 224,593 |
| 18/11/25 | 3.44 | 3.97 | 3.425 | 3.91 | 325,762 |
| 17/11/25 | 3.24 | 3.50 | 3.23 | 3.50 | 151,895 |
| 14/11/25 | 3.03 | 3.30 | 3.00 | 3.24 | 268,226 |
| 13/11/25 | 3.35 | 3.5895 | 3.08 | 3.10 | 196,086 |
| 12/11/25 | 3.28 | 3.44 | 3.07 | 3.41 | 155,507 |
| 11/11/25 | 3.15 | 3.33 | 3.072 | 3.27 | 86,586 |
| 10/11/25 | 3.12 | 3.39 | 3.0972 | 3.20 | 122,558 |
| 07/11/25 | 2.98 | 3.20 | 2.9638 | 3.20 | 140,972 |
|
|
||||
|
|
||||
|
|